BROADVIEW ADVISORS LLC: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BROADVIEW ADVISORS LLC on GMED, newest first. How the timeline and the estimate are built.

BROADVIEW ADVISORS LLC held 147,275 GMED shares at 2019-06-30 per its 13F-HR filed 2019-08-14.

the latest 13F is the newest step

period ended2019-06-30
13F 147,275 shares
Change vs previous 13F -2,200 shares
1.92% of the 13F portfolio, value $6,230,000.
13F-HR 0001255858-19-000005 filed by BROADVIEW ADVISORS LLC
Filed 2019-08-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:55:43 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2019-03-31
13F 149,475 shares
Change vs previous 13F +4,200 shares
2.01% of the 13F portfolio, value $7,386,000.
13F-HR 0001255858-19-000004 filed by BROADVIEW ADVISORS LLC
Filed 2019-05-15 (acceptance time not in the bulk data set), ingested 2026-10-07 18:56:23 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2018-12-31
13F 145,275 shares
Change vs previous 13F +17,625 shares
1.81% of the 13F portfolio, value $6,288,000.
13F-HR 0001255858-19-000002 filed by BROADVIEW ADVISORS LLC
Filed 2019-02-13 (acceptance time not in the bulk data set), ingested 2026-10-07 19:02:51 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2018-09-30
13F 127,650 shares
Change vs previous 13F not available
1.23% of the 13F portfolio, value $7,245,000.
13F-HR 0001255858-18-000006 filed by BROADVIEW ADVISORS LLC
Filed 2018-11-09 (acceptance time not in the bulk data set), ingested 2026-10-07 19:03:47 UTC
Acceptance time not in the bulk data set (spec §4.2).